Aquatic Capital Management
ATOS icon

Aquatic Capital Management’s Atossa Therapeutics ATOS Stock Holding History

Aquatic Capital Management’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-127
Closed -$2K – 1172
2022
Q2 		$2K Sell
127
-166
-57% -$2.62K ﹤0.01% 1103
2022
Q1 		$6K Buy
+293
New +$5.95K 0.01% 780

Other funds holding ATOS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Laurion Capital Management
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Aquatic Capital Management's ATOS Position: Q3 2022 in Review

Aquatic Capital Management sold out of Atossa Therapeutics (ATOS) in Q3 2022, closing a stake of 127 shares — an estimated $2K sold.

Aquatic Capital Management first reported a position in ATOS in Q1 2022 and held it in 2 quarters. The position peaked at $6K in Q1 2022. 56 funds tracked by Wall St. Rank hold ATOS as of Q3 2022.

  • Aquatic Capital Management reported no remaining Atossa Therapeutics position as of Q3 2022 after selling out during the quarter.
  • Aquatic Capital Management sold 127 Atossa Therapeutics shares in Q3 2022, an estimated $2K.
  • Aquatic Capital Management first reported a position in Atossa Therapeutics in Q1 2022 and held it in 2 quarters.
  • Aquatic Capital Management's Atossa Therapeutics position peaked at $6K in Q1 2022.
  • 56 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q3 2022.

Based on Aquatic Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.